Author(s): Shazma Imam, Priti Sharma, Dinesh Kumar Mehta, Sandeep Joshi, Rina Das

Email(s): dkmehta17@rediffmail.com

DOI: 10.5958/0974-360X.2020.00654.X   

Address: Shazma Imam1, Priti Sharma1, Dinesh Kumar Mehta1*, Sandeep Joshi2, Rina Das1
1MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala- Haryana (India) - 133207 2MM Institute of Medical Sciences and Research, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala- Haryana (India)-133207.
*Corresponding Author

Published In:   Volume - 13,      Issue - 8,     Year - 2020


ABSTRACT:
Objectives: This study aimed to explore the prescribing pattern of steroids among patients from different departments and study the most commonly prescribed corticosteroid medications and the assessment of patient knowledge about the use of corticosteroids. Methods: We conducted a prospective observational study on 120 patients receiving corticosteroids in the department of General medicine, Respiratory and Orthopedic in a tertiary care teaching hospital for the period of 6 months. Inpatients between 18-60 years receiving corticosteroid therapy were included in the study, exclusion of those patients who were under critical condition, lactating and nursing mothers and those not willing to sign on inform consent form. Key findings: The study involved 120 patients to evaluate the appropriate use of corticosteroids. The analysis of prescription was done and 24% of the prescriptions were found with drug interactions, the majority of drug interactions were minor (72%), followed by moderate (26%) and no severe interaction was found, and 76% were without interactions. Total 29(24.1%) side effects were found in the study due to corticosteroid use, hypertension was detected in 8 (28%), hyperglycemia in 7 (24%), sleep disturbance in 5 (17%), weight gain in 5 (17%) and gastrointestinal upset in 4 (14%). The use of inhaler was improved in patients from 55% to 83%. Conclusions: The study was found to be rational as the majority of interactions were minor, followed by moderate and no severe interaction was found. Greater awareness for use of corticosteroids is essential; therefore, strategies to improve drug safety, and better patients outcome. Prevention of side effects and rational prescribing can be better achieved by clinical pharmacist’s intervention in patient care.


Cite this article:
Shazma Imam, Priti Sharma, Dinesh Kumar Mehta, Sandeep Joshi, Rina Das. Corticosteroid Utilization Pattern: A Prospective study at a Tertiary Care Teaching Hospital. Research J. Pharm. and Tech. 2020; 13(8):3697-3701. doi: 10.5958/0974-360X.2020.00654.X


REFERENCE:
1.    Kendall EC. Nobel lecture: The development of cortisone as therapeutic agent. 2013:21-25.
2.    Kendall EC, Reichstein T, Hench SP.  Nobel lecture: The development of cortisone as a therapeutic agent. 1950:271-280.
3.    Joseph J. What is corticosteroid phobia? Contact magazine news 2013;102-115
4.    Tuder RM, Petrache I. Pathogenesis of chronic obstructive pulmonary disease. J Clin Invest   2012:122(8);2749–55.
5.    Mathers CD, Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLOS Med 2006;3(11):442-8.
6.    Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370:765–73.
7.    Qiu Y, Zhu J, Bandi V, Atmar RL, Hattotuwa K, Guntupalli KK, Jeffery PK. Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;168:968–75.
8.    Fujimoto K, Yasuo M, Urushibata K, Hanaoka M, Koizumi T, Kubo K. Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease. Eur Respir J 2005;25:640–6.
9.    Hurst JR, Perera WR, Wilkinson TMA, Donaldson GC, Wedzicha JA. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:71–8.
10.    Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung Disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med 2017;195(5):557-82.
11.    Walters JA, Tan DJ, White CJ, Gibson PG, Wood-Baker R, Walters EH. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014:1288.
12.    Suissa S, Barnes PJ. Inhaled corticosteroids in COPD: the case against. European Respiratory Journal 2009;34:13-16.
13.    Holgate S.T., Polosa R. Treatment strategies for allergy and asthma. Nat Rev Immunol 2008;8:218–30.
14.    Jeffery PK. Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc Am Thor Soc 2004;1:176–83.
15.    Charan NB, Baile EM, Pare PD. Bronchial vascular congestion and angiogenesis. Eur Respir J 1997;10:1173–80.
16.    Kumar SD, Emery MJ, Atkins ND, Danta I, Wanner A. Airway mucosal blood flow in bronchial asthma. Am J Respir Crit Care Med 1998;158:153–6.
17.    Mendes ES, Campos MA, Hurtado A, Wanner A. Effect of montelukast and fluticasone propionate on airway mucosal blood flow in asthma. Am J Respir Crit Care Med 2004;169:1131–4.
18.    Kanazawa H, Asai K, Hirata K, Yoshikawa J. Vascular involvement in exercise-induced airway narrowing in patients with bronchial asthma. Chest 2002;122:166–70.
19.    Kanazawa H, Nomura S, Yoshikawa J. Role of microvascular permeability on physiologic differences in asthma and eosinophilic bronchitis. Am J Respir Crit Care Med 2004;169:1125–30.
20.    Brown RH, Zerhouni EA, Mitzner W. Airway edema potentiates airway reactivity. J Appl Physiol 1995;79:1242–8.
21.    Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014;43(2):343-73.
22.    Krasselt M, Baerwald C.  The current relevance and use of prednisone in rheumatoid arthritis 2014;10(5):557-71.
23.    Anusreeraj RS, Prejith P, Diya S, Juliya J, Sivakumar R. A prospective study on drug utilization pattern of glucocorticoids in pulmonology department in a tertiary care teaching hospital. World journal of pharmacy and pharmaceutical science 2016;1511-7.
24.    Ference JD, Last AR. Choosing topical corticosteroids. American family Physician. 2009;79(2):51-9.
25.    Schweiger TA, Zdanowicz M. Systemic corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Am J Med 2010; 67(13):1061–9.
26.    Min KH, Ree CK, Jung JY, Suh MW. Characteristics of Adverse Effects When Using High Dose Short Term Steroid Regimen. Korean J Audiol 2012;16(2):65–70.

Recomonded Articles:

Author(s): Nimbalkar V.V., Pansare P.M., Nishane B.B.

DOI: 10.5958/0974-360X.2015.00310.8         Access: Open Access Read More

Author(s): Rakhi Mehra, Renu Makhija, Neera Vyas

DOI: Not Available         Access: Open Access Read More

Author(s): Koushika Das, Pranit Krishna, Avipsha Sarkar, Shanmuga Sundari Ilangovan, Shampa Sen

DOI: 10.5958/0974-360X.2017.00267.0         Access: Open Access Read More

Author(s): U.S Mahadeva Rao, Khamsah Suryati Mohd, Abdurrazaq Muhammad, Bashir Ado Ahmad, Mohaslinda Mohamad, Rosmawati Mat Ali

DOI: Not Available         Access: Open Access Read More

Author(s): Sandeep D. S, Prashant Nayak, Jobin Jose, Rishal Relita M, Sumana D. R.

DOI: 10.5958/0974-360X.2017.00317.1         Access: Open Access Read More

Author(s): Abhirup Dey, Mangala Lakshmi Ragavan, Sanjeeb Kumar Mandal, Nilanjana Das

DOI: 10.5958/0974-360X.2017.00136.6         Access: Open Access Read More

Author(s): Raj Kumar R, Praveen D, Palani Shanmugasundaram

DOI: 10.5958/0974-360X.2016.00164.5         Access: Open Access Read More

Author(s): Rahar Sandeep, Nagpal Navneet, Swami Gaurav, Arora Manisha, Bansal Suraj, Goyal Sandeep, Singla Shwali, Singh Preeti, Kapoor Reni

DOI: Not Available         Access: Open Access Read More

Author(s): V. Padmaharish

DOI: 10.5958/0974-360X.2016.00190.6         Access: Closed Access Read More

Author(s): Santhosh Kumar V, Praveen D

DOI: 10.5958/0974-360X.2016.00123.2         Access: Open Access Read More

Author(s): Rekha Rajendran, R Hemachander, T Ezhilarasan, C Keerthana, DL Saroja, KV Saichand, Mohamed Gasim Abdullah

DOI: Not Available         Access: Open Access Read More

Author(s): P. Geetha, M. Kousalya, S. Geetha Lakshmi, R. Gopi.

DOI: 10.5958/0974-360X.2016.00046.9         Access: Open Access Read More

Author(s): A. Julius, Ramachandran Vedasendiyar, Archana Devakannan, Sujatha Rajaraman, Balamurugan Rangasamy, V. Saravanan

DOI: 10.5958/0974-360X.2017.00062.2         Access: Open Access Read More

Author(s): M. Sumithra, Avantika Prabhabanik

DOI: 10.5958/0974-360X.2017.00036.1         Access: Open Access Read More

Author(s): Praveen D, Ranadheer Chowdary P, Gandikota Thanmayi, Gangabathina Poojitha, Vijey Aanandhi M

DOI: 0.5958/0974-360X.2016.00047.0         Access: Open Access Read More

Author(s): Niha Naveed, Karthikeyan Murthykumar, Subasree Soundarajan, Sripradha Srinivasan

DOI: Not Available         Access: Open Access Read More

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags